PMS-ERLOTINIB

ਉਤਪਾਦ ਝਲਕ

About PMS-ERLOTINIB

PMS-ERLOTINIB is a prescription medication containing the active ingredient Erlotinib Hydrochloride, used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to a class of drugs known as epidermal growth factor receptor (EGFR) inhibitors.

Key Benefits & Uses

• Treatment of non-small cell lung cancer (NSCLC) in patients with specific EGFR mutations
• Treatment of pancreatic cancer in combination with gemcitabine
• May be used as a maintenance therapy in patients with NSCLC who have responded to initial chemotherapy

Active Ingredient & Action

Erlotinib Hydrochloride works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, which is involved in the signaling pathway that promotes cancer cell growth and survival. By blocking this pathway, Erlotinib Hydrochloride helps to slow down or stop the growth of cancer cells.

Important Notes

PMS-ERLOTINIB should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration schedule to minimize the risk of side effects. Patients with a history of interstitial lung disease or radiation pneumonitis should be closely monitored while taking PMS-ERLOTINIB. Common side effects may include rash, diarrhea, and fatigue.